
GSK at ESMO (Kyle LaHucik for Endpoints News)
GSK steps in for J&J’s license of Arrowhead’s hepatitis B drug, plans combo study with its own candidate
British drugmaker GSK plans to acquire an experimental hepatitis B drug from Johnson & Johnson and its developer Arrowhead Pharmaceuticals and then combine the siRNA …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.